Assessment of disease activity control and evaluation strategy in patients with Takayasu arteritis undergoing cardiac surgery: a retrospective cohort study - Summary - MDSpire
Advertisement
Assessment of disease activity control and evaluation strategy in patients with Takayasu arteritis undergoing cardiac surgery: a retrospective cohort study
To evaluate the clinical safety and efficacy of a multidisciplinary strategy for managing disease activity in Takayasu's arteritis (TAK) patients undergoing cardiac surgery.
Key Findings:
The TAK cohort had a higher incidence of surgical site complications compared to controls (17.19% vs. 0%, P = 0.003).
No significant differences in early postoperative mortality/complications or mid-term survival were observed between TAK and NTAK patients.
TAK patients had a significantly higher incidence of cardiovascular re-hospitalization (sHR: 3.487; 95% CI: 1.414–8.559; P = 0.007) and new cardiovascular surgery (sHR: 6.342; 95% CI: 1.325–30.347; P = 0.021).
The risk of structural reoperation due to initial surgical failure was not significantly different between cohorts (sHR: 1.077; 95% CI: 0.151–7.705; P = 0.941).
Interpretation:
The multidisciplinary disease activity control strategy did not increase mortality or major perioperative complications for TAK patients compared to matched controls.
Limitations:
The study is retrospective and conducted at a single center, which may limit generalizability.
Sample size may not be sufficient to detect all potential differences in outcomes.
Conclusion:
The implementation of a multidisciplinary approach for managing TAK patients undergoing cardiac surgery did not increase immediate surgical risks compared to non-TAK controls.
Catch the recording of an exclusive webinar featuring renowned experts Dr. Tom C. Nguyen and Dr. Mehrdad Ghoreishi as they explore the future of aortic surgery.
